iBio, Inc. (IBIO)

Nasdaq: IBIO · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2008

Grade3.4

◀ Past 2.1● Present 3.4▶ Future 4.0

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in June.

Income statement, by fiscal year, newest first
Fiscal year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Report filed	Aug 28, 2026	Sep 5, 2025	Sep 20, 2024	Sep 27, 2023	Oct 11, 2022	Sep 28, 2021	Oct 13, 2020	Aug 26, 2019	Sep 18, 2018	Sep 15, 2017
Revenue	100,000	400,000	225,000	0	1,884,000^r	2,371,000	1,638,000	2,018,000	444,000	394,000
Cost of revenue	·	·	·	·	216,000	1,462,000	703,000	·	·	·
Gross profit	·	·	·	·	2,167,000	909,000	935,000	·	·	·
Research and development	19,643,000	8,312,000	5,185,000	10,327,000	9,827,000^r	9,989,000	3,573,000^r	5,474,000	3,986,000	4,117,000
General and administrative	10,595,000	10,690,000	11,674,000	19,016,000	21,754,000^r	22,031,000	11,365,000^r	12,332,000	10,685,000	10,551,000
Total operating expenses	35,241,000	19,002,000	16,859,000	29,343,000	31,581,000^r	32,020,000	14,938,000^r	17,806,000	14,671,000	14,668,000
Operating income	-35,141,000	-18,602,000	-16,634,000	-29,343,000	-29,697,000^r	-31,111,000	-14,003,000	-15,788,000	-14,227,000	-14,274,000
Interest expense	53,000	212,000	172,000	83,000	1,412,000	2,454,000	2,466,000	1,900,000	1,915,000	1,929,000
Interest and investment income	2,150,000	437,000	363,000	213,000	177,000^r	140,000	15,000	75,000	15,000	39,000
Other income (expense), net	·	·	·	·	6,000	·	·	·	·	·
Total non-operating income (expense)	2,097,000	225,000	1,191,000	32,000	184,000^r	7,898,000	-2,441,000	-1,809,000	-1,881,000	-1,865,000
Income before income taxes	-33,044,000	-18,377,000	·	·	·	·	·	·	·	·
Income tax expense	0	0	0	0	0	0	0	0	0	0
Income from continuing operations	·	-18,377,000	-15,443,000	-29,311,000	-29,513,000	·	·	·	·	·
Income from discontinued operations	·	·	-9,464,000	-35,699,000	-20,791,000	·	·	·	·	·
Net income including non-controlling interests	-33,044,000	-18,377,000	-24,907,000	-65,010,000	-50,304,000	-23,213,000	-16,444,000	-17,597,000	-16,108,000	-16,139,000
Net income to non-controlling interests	·	·	·	·	-1,000	-6,000	-5,000	-4,000	-3,000	-1,607,000
Net income	-33,044,000	-18,377,000	-24,907,000	-65,010,000	-50,303,000	-23,207,000	-16,439,000	-17,593,000	-16,105,000	-14,532,000
Net income to common shareholders	-33,044,000	-18,377,000	·	-29,311,000	-29,600,000^r	-23,467,000	-38,260,000	-17,853,000	-16,365,000	-14,622,000
Earnings per share, basic	-0.32	-1.75	-6.50	-106.19^r	-115.60^b	-60.00^b	·	·	·	·
Earnings per share, diluted	-0.32	-1.75	-6.50	-106.19^r	-115.60^b	-60.00^b	·	·	·	·
Earnings per share, basic and diluted	·	·	·	·	·	-2.40^b	-12.20^b	-18.80^b	-30.80^b	-32.80^rb
Weighted average shares, basic	104,060,000	10,499,000	3,831,000	612,000^r	436,050^b	391,250^b	·	·	·	·
Weighted average shares, diluted	104,060,000	10,499,000	3,831,000	612,000^r	436,050^b	391,250^b	·	·	·	·
Weighted average shares, basic and diluted	·	·	·	·	·	9,781,000^b	3,139,750^b	946,300^b	531,550^b	445,550^rb

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-20 reverse split of Nov 2023.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues
us-gaap:SalesRevenueNet

Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold

Gross profit revenue less the cost of what it soldus-gaap:GrossProfit

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing cost

us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense

Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Income from continuing operations profit from the businesses it keeps

us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperations

Income from discontinued operations profit or loss from businesses it sold or closedus-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax

Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss

Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

SI Assistanton IBIO · research, not advice